Revolutionary Asthma Medication Emerges as Potential Game-Changer for Food Allergy Relief

Scientists at Northwestern University have made an exciting discovery. They found that Zileuton, a drug used for asthma, can almost completely prevent severe allergic reactions to food in mice. This breakthrough could pave the way for new treatments for the millions of people with food allergies.

Dr. Stephanie Eisenbarth, who leads the research, and her team focused on Zileuton because it targets a newly found immune pathway. They discovered that Zileuton reduced the risk of anaphylaxis—a quick and dangerous allergic response—from 95% to just 5%. That’s a huge change.

What’s surprising is how effective Zileuton turned out to be. The researchers identified a specific gene, DPEP1, that plays a critical role in these allergic reactions. By using Zileuton, they blocked inflammatory molecules called leukotrienes, which are already known to affect asthma.

Dr. Eisenbarth expressed her astonishment at the results, saying, “It was shocking how well Zileuton worked.” Dr. Adam Williams, a co-researcher, highlighted that this approach is new and different from existing treatments. He explained that food allergies can lead to severe reactions from unexpected sources, like hidden peanuts in a dish. For parents or those with food allergies, a pill that can offer protection would be a game changer.

Food allergies currently impact over 33 million people in the U.S.—about 10% of the population. Unfortunately, the existing treatments are limited. There’s an oral therapy for peanuts that may cause reactions and an expensive injection that doesn’t work for everyone. Zileuton could be a simpler alternative, taken as a pill ahead of time to prevent anaphylaxis.

The research team has already started a small trial to see if the drug’s protective effects translate to humans. Interestingly, their findings may also shed light on why some people test positive for allergies but don’t have any reactions when they eat those foods.

Dr. Eisenbarth noted that understanding this could explain why certain individuals who are allergic in theory can still eat certain foods without issues. This could open up new avenues to explore food allergies and why they affect some people more severely than others.

The study highlights a broader movement in research—looking at unique and innovative ways to tackle issues that impact many lives. As we seek better solutions for food allergies, Zileuton’s promise may lead to improved safety and quality of life for those affected.

For more detailed information, you can find the original research published in Science.

Source link